Atlas Trials

Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

Clinical trial NCT04050098 · UNKNOWN

Trial details

NCT number
NCT04050098
Sponsor
LG Chem
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type2 Diabetes
Start date
2019-11-01
Primary completion
2019-11-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.